Lab Alumni
Lab members who transitioned to new positions in 2016
Cheng-Zhong Zhang, PhD
Member 2011 - 2016 (Staff Scientist)
PhD, Caltech
Current Position: Assistant Professor of Biomedical Informatics, Harvard Medical School
I am interested in novel genomic technologies, especially single-cell based methods for better understanding of genome evolution, mutagenesis, and genome organization.
“What I cannot create, I do not understand.” – Richard Feynman
617-432-1394
Email Dr. Zhang
Member 2011 - 2016 (Staff Scientist)
PhD, Caltech
Current Position: Assistant Professor of Biomedical Informatics, Harvard Medical School
I am interested in novel genomic technologies, especially single-cell based methods for better understanding of genome evolution, mutagenesis, and genome organization.
“What I cannot create, I do not understand.” – Richard Feynman
617-432-1394
Email Dr. Zhang
Alice Berger, PhD
Member 2011 - 2016 (Research Fellow)
PhD, Weill Cornell Graduate School of Medical Sciences
Current Position: Assistant Professor, Fred Hutchinson Cancer Research Institute, Seattle, WA
I am passionate about systematically uncovering the molecular basis for cancer to enable new opportunities in cancer treatment. I use a combination of genomics, molecular biology, and high-throughput experimental assays to discover the genetic changes that are required for cancer development and maintenance.
My recent focus has been on the genomic description of lung adenocarcinoma and target identification and validation of lung adenocarcinoma oncogenes. My ultimate goal is to diminish the suffering caused by cancer through development of preventative or curative treatment strategies.
"Unfortunately, nature seems unaware of our intellectual need for convenience and unity, and very often takes delight in complication and diversity." - Santiago Ramon y Cajal
Email Dr. Berger
Member 2011 - 2016 (Research Fellow)
PhD, Weill Cornell Graduate School of Medical Sciences
Current Position: Assistant Professor, Fred Hutchinson Cancer Research Institute, Seattle, WA
I am passionate about systematically uncovering the molecular basis for cancer to enable new opportunities in cancer treatment. I use a combination of genomics, molecular biology, and high-throughput experimental assays to discover the genetic changes that are required for cancer development and maintenance.
My recent focus has been on the genomic description of lung adenocarcinoma and target identification and validation of lung adenocarcinoma oncogenes. My ultimate goal is to diminish the suffering caused by cancer through development of preventative or curative treatment strategies.
"Unfortunately, nature seems unaware of our intellectual need for convenience and unity, and very often takes delight in complication and diversity." - Santiago Ramon y Cajal
Email Dr. Berger
Nathan Kaplan, BS, MS
Member 2011 - 2016 (Lead Research Technician)
BS, MS, Brandeis University
Current Position:
I am working on building mouse models for use in studying pancreatic neuroendocrine tumors, and also the testing of small molecule inhibitor therapies on those mice.
617-714-7244
Email Mr. Kaplan
Member 2011 - 2016 (Lead Research Technician)
BS, MS, Brandeis University
Current Position:
I am working on building mouse models for use in studying pancreatic neuroendocrine tumors, and also the testing of small molecule inhibitor therapies on those mice.
617-714-7244
Email Mr. Kaplan
Fujiko Duke, BS
Member 2010 - 2016 (Senior Research Technician)
BS, Miami University, OH
Current Position: Gritstone Oncology, Cambridge, MA
While in the Meyerson laboratory I worked with the pathogen discovery team and also with Alice Berger on RITI, a novel oncogene in lung adenocarcinoma.
My goal is to learn how to do something new each year.
Email Ms. Duke
Member 2010 - 2016 (Senior Research Technician)
BS, Miami University, OH
Current Position: Gritstone Oncology, Cambridge, MA
While in the Meyerson laboratory I worked with the pathogen discovery team and also with Alice Berger on RITI, a novel oncogene in lung adenocarcinoma.
My goal is to learn how to do something new each year.
Email Ms. Duke
Luc de Waal, PhD
Member 2011 - 2016 (Graduate Student)
PhD, Utrecht University (Advisor: Dr. Matthew Meyerson)
Current Position: Research Scientist Biology I, C4 Therapeutics, Cambridge, MA
My project focused on characterizing the mechanism of action of a novel small molecule that exposes a novel cancer dependency.
My goal in science is to increase our knowledge of disease and directly translate that into improved treatments or even new drugs that will improve the quality of life of patients.
“Science knows no country, because knowledge belongs to humanity, and is the torch which illuminates the world. Science is the highest personification of the nation because that nation will remain the first which carries the furthest the works of thought and intelligence.” – Louis Pasteur
Email Dr. de Waal
Member 2011 - 2016 (Graduate Student)
PhD, Utrecht University (Advisor: Dr. Matthew Meyerson)
Current Position: Research Scientist Biology I, C4 Therapeutics, Cambridge, MA
My project focused on characterizing the mechanism of action of a novel small molecule that exposes a novel cancer dependency.
My goal in science is to increase our knowledge of disease and directly translate that into improved treatments or even new drugs that will improve the quality of life of patients.
“Science knows no country, because knowledge belongs to humanity, and is the torch which illuminates the world. Science is the highest personification of the nation because that nation will remain the first which carries the furthest the works of thought and intelligence.” – Louis Pasteur
Email Dr. de Waal
Joshua Campbell, PhD
Member 2013 - 2016 (Research Fellow)
PhD, Boston University
Current Position: Assistant Professor at Boston University School of Medicine, Boston, MA
I am interested in using high-throughput genomics techniques such and DNA and RNA sequencing to understand the initiation and progression of lung cancer and to develop novel diagnostic biomarkers for the early detection of lung cancer.
“The most exciting phrase to hear in science, the one that heralds new discoveries, is not 'Eureka!' but 'That's funny...' ” - Isaac Asimov
LinkedIn: www.linkedin.com/pub/josh-campbell/1/a46/b33/
The Campbell Laboratory
Email Dr. Campbell
Member 2013 - 2016 (Research Fellow)
PhD, Boston University
Current Position: Assistant Professor at Boston University School of Medicine, Boston, MA
I am interested in using high-throughput genomics techniques such and DNA and RNA sequencing to understand the initiation and progression of lung cancer and to develop novel diagnostic biomarkers for the early detection of lung cancer.
“The most exciting phrase to hear in science, the one that heralds new discoveries, is not 'Eureka!' but 'That's funny...' ” - Isaac Asimov
LinkedIn: www.linkedin.com/pub/josh-campbell/1/a46/b33/
The Campbell Laboratory
Email Dr. Campbell
Joshua Francis, PhD
Member 2011 - 2016 (Research Scientist II)
PhD, University of Virginia
Current Position: Gritstone Oncology, Cambridge, MA
My work in the lab focused on using sequencing technologies to understand the genomic events that contribute to cancer.
Email Dr. Francis
Member 2011 - 2016 (Research Scientist II)
PhD, University of Virginia
Current Position: Gritstone Oncology, Cambridge, MA
My work in the lab focused on using sequencing technologies to understand the genomic events that contribute to cancer.
Email Dr. Francis
Chandra Sekhar Pedamallu, PhD
Member 2010 - 2016 (Senior Computational Biologist)
PhD, Nanyang Technological University, Singapore
Current Position: Lead, Next generation sequencing pipeline, Sanofi, Cambridge, MA
My research interests while in the Meyerson laboratory included pathogen discovery in cancer and diseased tissues, drug discovery, cancer genomics, cloud computing and distributed computing.
I aim to contribute to curing cancer and to making this world a great place to live in.
LinkedIn: https://www.linkedin.com/in/chandrasekharpedamallu
Google citations: http://scholar.google.com/citations?user=gjMIxKYAAAAJ&hl=en
Email Dr. Pedamallu
Member 2010 - 2016 (Senior Computational Biologist)
PhD, Nanyang Technological University, Singapore
Current Position: Lead, Next generation sequencing pipeline, Sanofi, Cambridge, MA
My research interests while in the Meyerson laboratory included pathogen discovery in cancer and diseased tissues, drug discovery, cancer genomics, cloud computing and distributed computing.
I aim to contribute to curing cancer and to making this world a great place to live in.
LinkedIn: https://www.linkedin.com/in/chandrasekharpedamallu
Google citations: http://scholar.google.com/citations?user=gjMIxKYAAAAJ&hl=en
Email Dr. Pedamallu
Lab members who transitioned to independent positions in 2015
Angela Brooks, PhD
Member 2011 - 2015 (Research Fellow)
PhD, UC Berkeley
Current Position: Assistant Professor of Biomolecular Engineering, University of California, Santa Cruz
I am using and developing computational approaches to characterize somatic alterations that disrupt the regulation of pre-mRNA splicing. Additionally, I’m working on a high-throughput functional study to map somatic mutations in lung adenocarcinoma to effects on cancer-related pathways.
I hope that my research accomplishments will lead to a better understanding of how cancer genome alterations lead to disruption of cellular processes, which may lead to additional cancer therapeutic approaches. I also hope to continue to teach and mentor others in scientific research so that others can share in the excitement of scientific discovery.
The Brooks Laboratory
Email Dr. Brooks
Member 2011 - 2015 (Research Fellow)
PhD, UC Berkeley
Current Position: Assistant Professor of Biomolecular Engineering, University of California, Santa Cruz
I am using and developing computational approaches to characterize somatic alterations that disrupt the regulation of pre-mRNA splicing. Additionally, I’m working on a high-throughput functional study to map somatic mutations in lung adenocarcinoma to effects on cancer-related pathways.
I hope that my research accomplishments will lead to a better understanding of how cancer genome alterations lead to disruption of cellular processes, which may lead to additional cancer therapeutic approaches. I also hope to continue to teach and mentor others in scientific research so that others can share in the excitement of scientific discovery.
The Brooks Laboratory
Email Dr. Brooks
Marcin Imielinski, MD, PhD
Member 2010 - 2015 (Clinical Fellow)
MD, PhD, University of Pennsylvania School of Medicine
Current Position: (1) Assistant Professor of Computational Genomics,
Institute for Computational Biomedicine, Weill Cornell Medical College
(2) Assistant Professor of Pathology and Laboratory Medicine,
Department of Pathology and Laboratory Medicine, Weill Cornell Medical College
(3) Core Member, New York Genome Center
I am interested in applying integrative computational models to ‘omic data to uncover dysregulated pathways and networks in cancer. I am also interested in the clinical application of high dimensional diagnostics and quantitative molecular pathology to help guide prognosis and treatment in cancer patients.
212-746-2040
weillcornell.org/maimielinski
Email Dr. Imielinski
Member 2010 - 2015 (Clinical Fellow)
MD, PhD, University of Pennsylvania School of Medicine
Current Position: (1) Assistant Professor of Computational Genomics,
Institute for Computational Biomedicine, Weill Cornell Medical College
(2) Assistant Professor of Pathology and Laboratory Medicine,
Department of Pathology and Laboratory Medicine, Weill Cornell Medical College
(3) Core Member, New York Genome Center
I am interested in applying integrative computational models to ‘omic data to uncover dysregulated pathways and networks in cancer. I am also interested in the clinical application of high dimensional diagnostics and quantitative molecular pathology to help guide prognosis and treatment in cancer patients.
212-746-2040
weillcornell.org/maimielinski
Email Dr. Imielinski
Akinyemi I. Ojesina, MD, PhD
Member 2008 - 2015 (Research Fellow)
MD, University of Ibadan, Nigeria
PhD, Harvard University
Current Position: (1) Assistant Professor, Department of Epidemiology, University of Alabama at Birmingham
(2) Adjunct Faculty Investigator, HudsonAlpha Institute for Biotechnology
I am interested in understanding how somatic genomic alterations synergize with pathogenic infection to initiate and sustain tumor development. In addition, I seek to discover novel cancer-associated pathogens using next-generation sequencing. Ultimately, my goal is to provide insight into the genomic mechanisms of tumor initiation and progression in order to facilitate the development of (i) prognostic biomarkers for predicting the outcome of precancerous lesions, and (ii) targeted prophylactic therapies for the prevention of tumor progression.
"You don't discover new worlds by plying safe, conventional waters." - Bill Gates
205 934-7911
The Ojesina Laboratory
Email Dr. Ojesina
Member 2008 - 2015 (Research Fellow)
MD, University of Ibadan, Nigeria
PhD, Harvard University
Current Position: (1) Assistant Professor, Department of Epidemiology, University of Alabama at Birmingham
(2) Adjunct Faculty Investigator, HudsonAlpha Institute for Biotechnology
I am interested in understanding how somatic genomic alterations synergize with pathogenic infection to initiate and sustain tumor development. In addition, I seek to discover novel cancer-associated pathogens using next-generation sequencing. Ultimately, my goal is to provide insight into the genomic mechanisms of tumor initiation and progression in order to facilitate the development of (i) prognostic biomarkers for predicting the outcome of precancerous lesions, and (ii) targeted prophylactic therapies for the prevention of tumor progression.
"You don't discover new worlds by plying safe, conventional waters." - Bill Gates
205 934-7911
The Ojesina Laboratory
Email Dr. Ojesina
Hideo Watanabe, MD, PhD
Member 2007 - 2015 (Research Fellow)
MD, Keio University School of Medicine, Japan
PhD, Keio University Graduate School of Medicine, Japan
Current Position: (1) Assistant Professor, Division of Pulmonary, Critical Care & Sleep Medicine, Mount Sinai School of Med.
(2) Assistant Professor, Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine
My research interest is to extend a well-established concept in hematopoietic malignancy that transcriptional regulation of cell lineage plays key roles in their pathogenesis into the field of solid tumors, principally of lung cancers. I would like to make lung cancer a little better disease to deal with for the patients.
mountsinai.org/profiles/hideo-watanabe
The Watanabe Laboratory
Email Dr. Watanabe
Member 2007 - 2015 (Research Fellow)
MD, Keio University School of Medicine, Japan
PhD, Keio University Graduate School of Medicine, Japan
Current Position: (1) Assistant Professor, Division of Pulmonary, Critical Care & Sleep Medicine, Mount Sinai School of Med.
(2) Assistant Professor, Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine
My research interest is to extend a well-established concept in hematopoietic malignancy that transcriptional regulation of cell lineage plays key roles in their pathogenesis into the field of solid tumors, principally of lung cancers. I would like to make lung cancer a little better disease to deal with for the patients.
mountsinai.org/profiles/hideo-watanabe
The Watanabe Laboratory
Email Dr. Watanabe
Ganesh Shankar, MD, PhD
Member 2013 - 2015 (Clinical Fellow)
MD, Harvard Medical School
PhD, Harvard Medical School
Current Position: Neurosurgeon, Massachusetts General Hospital
I aim to understand how genomic alterations lead to tumors of the nervous system, with the goal of specializing in treating primary and secondary tumors involving the spinal axis.
(617) 726-5143
Email Dr. Shankar
Member 2013 - 2015 (Clinical Fellow)
MD, Harvard Medical School
PhD, Harvard Medical School
Current Position: Neurosurgeon, Massachusetts General Hospital
I aim to understand how genomic alterations lead to tumors of the nervous system, with the goal of specializing in treating primary and secondary tumors involving the spinal axis.
(617) 726-5143
Email Dr. Shankar
Guangwu Guo, PhD
Member 2013-2015 (Research Fellow)
PhD, Beijing Genomics Institute
Current Position: Postdoctoral Fellow, Lohr Laboratory, Dana-Farber Cancer Institute
The human genome can be divided into two main sections, the coding (2%) and non-coding (98%) portions. Studies have shown that non-coding DNA is very important in regulating gene expression. Systematic characterization of human cancer genomes has led to discovery of a wide range of genetic alterations that are associated with human cancers, but most of them reside within the protein-coding regions of genes. We have generated hundreds of whole genome sequencing, RNA-Seq and miR-Seq datasets in lung cancer.
The goal of my research is to discover functional non-coding genetic variants in the lung cancer genome and understand how they direct pathological expression of genes in lung cancer development and progression.
LinkedIn: http://www.linkedin.com/pub/guangwu-guo/82/989/69
617-869-6727
Email Dr. Guo
Member 2013-2015 (Research Fellow)
PhD, Beijing Genomics Institute
Current Position: Postdoctoral Fellow, Lohr Laboratory, Dana-Farber Cancer Institute
The human genome can be divided into two main sections, the coding (2%) and non-coding (98%) portions. Studies have shown that non-coding DNA is very important in regulating gene expression. Systematic characterization of human cancer genomes has led to discovery of a wide range of genetic alterations that are associated with human cancers, but most of them reside within the protein-coding regions of genes. We have generated hundreds of whole genome sequencing, RNA-Seq and miR-Seq datasets in lung cancer.
The goal of my research is to discover functional non-coding genetic variants in the lung cancer genome and understand how they direct pathological expression of genes in lung cancer development and progression.
LinkedIn: http://www.linkedin.com/pub/guangwu-guo/82/989/69
617-869-6727
Email Dr. Guo
Lab members who transitioned to new positions in 2014
Wenchu Lin, PhD
Member 2011 - 2014 (Staff Scientist)
PhD, MD Anderson Cancer Center, University of Texas
Current Position: Professor, High Magnetic Field Laboratory of the Chinese Academy of Sciences
My interests encompass cancer genetics and epigenetics, molecular mechanisms of neuroendocrine cancer and mouse models of human cancer. My goal is to contribute to better cancer diagnosis and treatment via discovery in cancer research.
The Lin Laboratory
Email Dr. Lin
Member 2011 - 2014 (Staff Scientist)
PhD, MD Anderson Cancer Center, University of Texas
Current Position: Professor, High Magnetic Field Laboratory of the Chinese Academy of Sciences
My interests encompass cancer genetics and epigenetics, molecular mechanisms of neuroendocrine cancer and mouse models of human cancer. My goal is to contribute to better cancer diagnosis and treatment via discovery in cancer research.
The Lin Laboratory
Email Dr. Lin
Ami Bhatt, MD, PhD
Member 2011 - 2014 (Clinical Fellow)
MD, PhD, University of California San Francisco
Current Position: Assistant Professor of Medicine and Genetics, Divisions of Hematology and BMT, Stanford University
269 Campus Drive
CCSR1155b
Palo Alto, CA 94305
As a physician and a biologist, my research program directly reflects my clinical experiences and interests, marrying the fields of infectious disease and hematology/oncology. Specifically, I am interested in the use of next generation sequencing to discover new disease-associated microbes and understand how the microbiome may (1) induce diseases, (2) alter clinical outcomes and (3) lead to infectious complications in patients with leukemia and lymphoma.
"Wisdom begins in wonder." – Socrates
650-498-4438
The Bhatt Laboratory
Email Dr. Bhatt
Member 2011 - 2014 (Clinical Fellow)
MD, PhD, University of California San Francisco
Current Position: Assistant Professor of Medicine and Genetics, Divisions of Hematology and BMT, Stanford University
269 Campus Drive
CCSR1155b
Palo Alto, CA 94305
As a physician and a biologist, my research program directly reflects my clinical experiences and interests, marrying the fields of infectious disease and hematology/oncology. Specifically, I am interested in the use of next generation sequencing to discover new disease-associated microbes and understand how the microbiome may (1) induce diseases, (2) alter clinical outcomes and (3) lead to infectious complications in patients with leukemia and lymphoma.
"Wisdom begins in wonder." – Socrates
650-498-4438
The Bhatt Laboratory
Email Dr. Bhatt
Tanaz Sharifnia, PhD
Member 2008 - 2014 (Graduate Student)
PhD, Harvard University (Advisor: Dr. Matthew Meyerson)
Current Position: Postdoctoral Fellow, Laboratory of Stuart Schreiber, Broad Institute
617-714-8231
Email Dr. Sharifnia
Member 2008 - 2014 (Graduate Student)
PhD, Harvard University (Advisor: Dr. Matthew Meyerson)
Current Position: Postdoctoral Fellow, Laboratory of Stuart Schreiber, Broad Institute
617-714-8231
Email Dr. Sharifnia
Lab members who transitioned to new positions in 2013
Rachel (Rienstra) Liao, PhD
Member 2009 - 2013 (Graduate Student)
PhD, Harvard University (Advisor: Dr. Matthew Meyerson)
Current Position: Senior Project Manager, Global Alliance for Genomics and Health/Broad Institute
My talk at the TCGA meeting in 2012.
617-714-7557
Email Dr. Liao
Member 2009 - 2013 (Graduate Student)
PhD, Harvard University (Advisor: Dr. Matthew Meyerson)
Current Position: Senior Project Manager, Global Alliance for Genomics and Health/Broad Institute
My talk at the TCGA meeting in 2012.
617-714-7557
Email Dr. Liao
Elena Helman, PhD
Member 2009 - 2013 (Graduate Student)
PhD, Harvard-MIT Division of Health Sciences and Technology (Advisor: Dr. Matthew Meyerson)
Current Position: Bioinformatics Analyst, Personalis Inc.
Email Dr. Helman
Member 2009 - 2013 (Graduate Student)
PhD, Harvard-MIT Division of Health Sciences and Technology (Advisor: Dr. Matthew Meyerson)
Current Position: Bioinformatics Analyst, Personalis Inc.
Email Dr. Helman
Alex Kostic, PhD
Member 2009 - 2013 (Graduate Student)
PhD, Harvard University (Advisor: Dr. Matthew Meyerson)
Current Position: Post-Doctoral Fellow, Xavier Lab, Massachusetts General Hospital and Broad Institute
617-714-7608
Email Dr. Kostic
Member 2009 - 2013 (Graduate Student)
PhD, Harvard University (Advisor: Dr. Matthew Meyerson)
Current Position: Post-Doctoral Fellow, Xavier Lab, Massachusetts General Hospital and Broad Institute
617-714-7608
Email Dr. Kostic
Joonil Jung, PhD
Member 2009 - 2013 (Research Fellow)
PhD, Brown University (Advisor: Kenneth Zaret, Ph.D.)
Postdoctoral Fellowship, University of Pennsylvania (Advisor: Nancy Bonini, Ph.D.)
Current Position: Principal Research Investigator, Sanofi Oncology
Member 2009 - 2013 (Research Fellow)
PhD, Brown University (Advisor: Kenneth Zaret, Ph.D.)
Postdoctoral Fellowship, University of Pennsylvania (Advisor: Nancy Bonini, Ph.D.)
Current Position: Principal Research Investigator, Sanofi Oncology
Trevor Pugh, PhD
Member 2010 - 2013 (Research Fellow)
PhD, University of British Columbia
Current Position: (1) Scientist and Lead of the Clinical Genomics Research Program Princess, Margaret Cancer Centre (2) Assistant Professor of Medical Biophysics, University of Toronto
(3) Lead, Clinical Genomics Program, Ontario Cancer Institute
416-634-7689
medbio.utoronto.ca/faculty/pugh
Email Dr. Pugh
Member 2010 - 2013 (Research Fellow)
PhD, University of British Columbia
Current Position: (1) Scientist and Lead of the Clinical Genomics Research Program Princess, Margaret Cancer Centre (2) Assistant Professor of Medical Biophysics, University of Toronto
(3) Lead, Clinical Genomics Program, Ontario Cancer Institute
416-634-7689
medbio.utoronto.ca/faculty/pugh
Email Dr. Pugh
Alumni who moved on from the Meyerson laboratory in 2012
Peter Hammerman, MD, PhD
Member 2009 - 2012 (Clinical Fellow)
BAS, Stanford University 1999
PhD, University of Pennsylvania 2005
MD, University of Pennsylvania 2006
Residency, Internal Medicine, Massachusetts General Hospital, 2006-2008
Current Position: Assistant Professor of Medicine, Dana-Farber Cancer Institute; Associate Member, Broad Institute
My work in the lab focuses on the identification of the genetic events that lead to human lung cancer. I study how changes in gene expression, DNA copy number and somatic mutations in lung cancer cells leads to transformation and how these genetic changes might be exploited to develop novel therapeutics for lung cancer.
617-632-6335
The Hammerman Laboratory
Email Dr. Hammerman
Member 2009 - 2012 (Clinical Fellow)
BAS, Stanford University 1999
PhD, University of Pennsylvania 2005
MD, University of Pennsylvania 2006
Residency, Internal Medicine, Massachusetts General Hospital, 2006-2008
Current Position: Assistant Professor of Medicine, Dana-Farber Cancer Institute; Associate Member, Broad Institute
My work in the lab focuses on the identification of the genetic events that lead to human lung cancer. I study how changes in gene expression, DNA copy number and somatic mutations in lung cancer cells leads to transformation and how these genetic changes might be exploited to develop novel therapeutics for lung cancer.
617-632-6335
The Hammerman Laboratory
Email Dr. Hammerman
Marilyn Hayes
Member 2006 - 2012 (Administrative Assistant to Dr. Matthew Meyerson)
I helped achieve the research goals of the lab by coordinating and managing its administrative needs.
Current position: Administrative Assistant to Dr. Adam Bass, Dana-Farber Cancer Institute
617-632-5707
Email Ms. Hayes
Member 2006 - 2012 (Administrative Assistant to Dr. Matthew Meyerson)
I helped achieve the research goals of the lab by coordinating and managing its administrative needs.
Current position: Administrative Assistant to Dr. Adam Bass, Dana-Farber Cancer Institute
617-632-5707
Email Ms. Hayes
Alex Ramos, PhD
Member 2006 - 2012 (Graduate Student)
PhD, Harvard University (Advisor: Dr. Matthew Meyerson)
Current Position: Software Engineer at Apple
Member 2006 - 2012 (Graduate Student)
PhD, Harvard University (Advisor: Dr. Matthew Meyerson)
Current Position: Software Engineer at Apple
Alumni who moved on from the Meyerson laboratory in 2011
Brittany Woods
Member 2010 - 2011 (Research Technician)
Current Position: Graduate student at Memorial Sloan-Kettering Cancer Canter
Thesis Project: Dissecting aberrant cytokine receptor signaling in the pathogenesis of myeloproliferative neoplasms
Member 2010 - 2011 (Research Technician)
Current Position: Graduate student at Memorial Sloan-Kettering Cancer Canter
Thesis Project: Dissecting aberrant cytokine receptor signaling in the pathogenesis of myeloproliferative neoplasms
Scott L. Carter, PhD
Member 2007 - 2011 (Graduate Student)
PhD, Harvard-MIT Division of Health Sciences and Technology (Advisor: Dr. Matthew Meyerson)
Current Position: (1) Assistant Professor, Dana-Farber Cancer Institute
(2) Assistant Professor, Harvard T.H. Chan School of Public Health
I currently work on statistical modeling of genome-scale cancer datasets. My particular interest are in mechanisms of somatic evolution and interactions between inherited germline variation and somatic transmission of alleles into the cancer genome.
617-632-3038
dfhcc.harvard.edu/carter
Email Dr. Carter
Member 2007 - 2011 (Graduate Student)
PhD, Harvard-MIT Division of Health Sciences and Technology (Advisor: Dr. Matthew Meyerson)
Current Position: (1) Assistant Professor, Dana-Farber Cancer Institute
(2) Assistant Professor, Harvard T.H. Chan School of Public Health
I currently work on statistical modeling of genome-scale cancer datasets. My particular interest are in mechanisms of somatic evolution and interactions between inherited germline variation and somatic transmission of alleles into the cancer genome.
617-632-3038
dfhcc.harvard.edu/carter
Email Dr. Carter
Se-Hoon Lee, MD, PhD
Member 2009 - 2011
PhD, Seoul National University College of Medicine
Assistant Professor, Seoul National University Hospital
I am focusing on the functional validation of genetic alterations found in primary lung cancer samples. I am interested in the prediction modeling of genetic alterations discovered by genome-based approaches. In the clinic, I also treat cancers of the head and neck, brain, and kidneys.
Email Dr. Lee
Member 2009 - 2011
PhD, Seoul National University College of Medicine
Assistant Professor, Seoul National University Hospital
I am focusing on the functional validation of genetic alterations found in primary lung cancer samples. I am interested in the prediction modeling of genetic alterations discovered by genome-based approaches. In the clinic, I also treat cancers of the head and neck, brain, and kidneys.
Email Dr. Lee
Lear Brace
Member 2009 - 2011 (Research Technician)
BS, Emmanuel College, Boston
Current Position: Graduate Student in the Department of Genetics and Complex Diseases, Harvard School of Public Health
Member 2009 - 2011 (Research Technician)
BS, Emmanuel College, Boston
Current Position: Graduate Student in the Department of Genetics and Complex Diseases, Harvard School of Public Health
Abbie Frederick
Member 2009 - 2011 (Research Associate)
Current Position: Graduate Student, Brown University
I am currently working on the identification and validation of key alterations in small cell lung cancer and liposarcoma through RNAi pooled screens and RNAseq.
Member 2009 - 2011 (Research Associate)
Current Position: Graduate Student, Brown University
I am currently working on the identification and validation of key alterations in small cell lung cancer and liposarcoma through RNAi pooled screens and RNAseq.
Shantanu Banerji, MD, FRCP(c)
Member 2007 - 2011 (Clinical Fellow)
BS, University of Manitoba, Canada
MD, University of Manitoba, Canada
Current Position: Assistant Professor of Medicine CancerCare, University of Manitoba, Canada
umanitoba.ca/SBanerji
Email Dr. Banerji
Member 2007 - 2011 (Clinical Fellow)
BS, University of Manitoba, Canada
MD, University of Manitoba, Canada
Current Position: Assistant Professor of Medicine CancerCare, University of Manitoba, Canada
umanitoba.ca/SBanerji
Email Dr. Banerji
Sue-Ann Woo, PhD
Member 2005 - 2011 (Research Fellow)
PhD, Harvard University
Current Position: Senior Scientific Liaison, Admera Health
908-222-0533
Email Dr. Woo
Member 2005 - 2011 (Research Fellow)
PhD, Harvard University
Current Position: Senior Scientific Liaison, Admera Health
908-222-0533
Email Dr. Woo
Jeonghee Cho, PhD
Member 2005 - 2011 (Research Fellow)
PhD, Tufts University
Current Position: Principal Investigator at Samsung Genome Institute
+82-2-2148-9814
Email Dr. Cho
Member 2005 - 2011 (Research Fellow)
PhD, Tufts University
Current Position: Principal Investigator at Samsung Genome Institute
+82-2-2148-9814
Email Dr. Cho
Alumni who left the Meyerson laboratory in 2010
Diana Hubbard, BA
Member 2009 - 2010 (Data Analyst)
BA, University of Chicago
Current Position: Graduate Student, Mathematics, Boston College
I am currently a graduate student in mathematics at Boston College studying geometry, topology and knot theory.
sites.google.com/dianadhubbard
Email Ms. Hubbard
Member 2009 - 2010 (Data Analyst)
BA, University of Chicago
Current Position: Graduate Student, Mathematics, Boston College
I am currently a graduate student in mathematics at Boston College studying geometry, topology and knot theory.
sites.google.com/dianadhubbard
Email Ms. Hubbard
Roel Verhaak , PhD
Member 2007 - 2010 (Research Fellow)
PhD, Erasmus University Medical Center, The Netherlands
Current Position: Associate Professor at MD Anderson Cancer Center, Department of Bioinformatics & Computational Biology
I am focusing on cancer genomics, in particular identification and characterization of transciptome based cancer subtypes.
713-563-2293
The Verhaak Laboratory
Email Dr. Verhaak
Member 2007 - 2010 (Research Fellow)
PhD, Erasmus University Medical Center, The Netherlands
Current Position: Associate Professor at MD Anderson Cancer Center, Department of Bioinformatics & Computational Biology
I am focusing on cancer genomics, in particular identification and characterization of transciptome based cancer subtypes.
713-563-2293
The Verhaak Laboratory
Email Dr. Verhaak
Kumiko Tanaka, MD
Member 2007 - 2010 (Research Technician)
MD, University of Southern California, Keck School of Medicine
Current Position: OB-GYN Resident at Dartmouth Hitchcock Medical Center
Email Dr. Tanaka
Member 2007 - 2010 (Research Technician)
MD, University of Southern California, Keck School of Medicine
Current Position: OB-GYN Resident at Dartmouth Hitchcock Medical Center
Email Dr. Tanaka
Adam Bass, MD
Member 2006 - 2010 (Clinical Fellow)
MD, Duke University School of Medicine
Current Position: Principal Investigator at Dana-Farber Cancer Institute and Harvard Medical School
Identification of somatic genomic alterations in gastrointestinal carcinomas and translation of findings to improved therapeutics.
617-632-5707
The Bass Laboratory
Email Dr. Bass
Member 2006 - 2010 (Clinical Fellow)
MD, Duke University School of Medicine
Current Position: Principal Investigator at Dana-Farber Cancer Institute and Harvard Medical School
Identification of somatic genomic alterations in gastrointestinal carcinomas and translation of findings to improved therapeutics.
617-632-5707
The Bass Laboratory
Email Dr. Bass
Amit Dutt, PhD
Member 2006 - 2010 (Research Fellow)
PhD, University of Zurich, Switzerland
Current Position: Assistant Professor, Ramalingaswami Fellow, at the Advanced Center for Treatment, Research, and Education in Cancer, Tata Memorial Center, Mumbai
The Dutt Laboratory
Email Dr. Dutt
Member 2006 - 2010 (Research Fellow)
PhD, University of Zurich, Switzerland
Current Position: Assistant Professor, Ramalingaswami Fellow, at the Advanced Center for Treatment, Research, and Education in Cancer, Tata Memorial Center, Mumbai
The Dutt Laboratory
Email Dr. Dutt
Craig Mermel, MD, PhD
Member 2006 - 2010 (Graduate Student)
MD, Harvard Medical School
PhD, Harvard University (Advisor: Dr. Matthew Meyerson)
Current Position: Resident in Pathology, Massachusetts General Hospital
(617) 726-2967
Email Dr. Mermel
Member 2006 - 2010 (Graduate Student)
MD, Harvard Medical School
PhD, Harvard University (Advisor: Dr. Matthew Meyerson)
Current Position: Resident in Pathology, Massachusetts General Hospital
(617) 726-2967
Email Dr. Mermel
Gad Getz, PhD
Member 2004 - 2010
MSc, Tel-Aviv University and Weizmann Institute of Science, Israel
PhD, Weizmann Institute of Science, Israel
Current Position: Director, Cancer Genomics Informatics and Computational Biology, Broad Institute
My main interest is to develop and apply statistical methods to discover the “driver” alterations in the cancer genome that are selected during tumor development, based on various genomic data types (e.g. sequencing copy-number, loss-of-heterozygosity), for The Cancer Genome Atlas and related projects.
617-714-7471
Email Dr. Getz
Member 2004 - 2010
MSc, Tel-Aviv University and Weizmann Institute of Science, Israel
PhD, Weizmann Institute of Science, Israel
Current Position: Director, Cancer Genomics Informatics and Computational Biology, Broad Institute
My main interest is to develop and apply statistical methods to discover the “driver” alterations in the cancer genome that are selected during tumor development, based on various genomic data types (e.g. sequencing copy-number, loss-of-heterozygosity), for The Cancer Genome Atlas and related projects.
617-714-7471
Email Dr. Getz
Tzu-Hsiu Chen, MS
Member 2002 -2010
Current Position: Senior Research Associate, Broad Institute
Using gene over-expression, anchorage independent growth assays, and shRNA techniques, I study the effects of inhibitors on novel tyrosine kinase mutants.
617-324-0212
Email Ms. Chen
Member 2002 -2010
Current Position: Senior Research Associate, Broad Institute
Using gene over-expression, anchorage independent growth assays, and shRNA techniques, I study the effects of inhibitors on novel tyrosine kinase mutants.
617-324-0212
Email Ms. Chen
Earlier Lab Alumni
Derek Chiang, PhD
Member 2005 - 2009 (Research Fellow)
PhD, University of California at Berkeley
BS, University of North Carolina
Current Position: Senior Investigator at Novartis Institutes for BioMedical Research
My primary interest is to develop computational algorithms for cancer genomics datasets, including oncogene discovery of liver cancers and transcriptome analyses.
Email Dr. Chiang
Member 2005 - 2009 (Research Fellow)
PhD, University of California at Berkeley
BS, University of North Carolina
Current Position: Senior Investigator at Novartis Institutes for BioMedical Research
My primary interest is to develop computational algorithms for cancer genomics datasets, including oncogene discovery of liver cancers and transcriptome analyses.
Email Dr. Chiang
Soyoung Yu
Member 2006 - 2009 (Sr. Research Technician)
BS, UMass Amherst
MBA, Seoul National University
Current Position: Business Development Specialist, Handok Pharmaceuticals, Korea
I evaluate and do business work to license pharmaceuticals.
Email Ms. Yu
Member 2006 - 2009 (Sr. Research Technician)
BS, UMass Amherst
MBA, Seoul National University
Current Position: Business Development Specialist, Handok Pharmaceuticals, Korea
I evaluate and do business work to license pharmaceuticals.
Email Ms. Yu
Mukundhan Ramaswami
Member 2006 - 2009
Member 2006 - 2009
Rameen Beroukhim, MD, PhD
Member 2005 - 2009 (Clinical Fellow)
AB, University of California at Berkeley
MPhil, University of Cambridge
PhD, University of Cambridge
MD, University of California at San Francisco
Current position: Assistant Professor of Medicine, Havard Medical School; Associate Member, Broad Institute
My primary interest is in understanding the heterogeneity observed across cancers through understanding their varied somatic genetics.
617-582-7941
The Beroukhim Lab
Email Dr. Beroukhim
Member 2005 - 2009 (Clinical Fellow)
AB, University of California at Berkeley
MPhil, University of Cambridge
PhD, University of Cambridge
MD, University of California at San Francisco
Current position: Assistant Professor of Medicine, Havard Medical School; Associate Member, Broad Institute
My primary interest is in understanding the heterogeneity observed across cancers through understanding their varied somatic genetics.
617-582-7941
The Beroukhim Lab
Email Dr. Beroukhim
Wendy Winckler, PhD
Member 2005 - 2008 (Research Fellow)
Current Position: Executive Director, Next Generation Diagnostics at Novartis Institutes for BioMedical Research
Member 2005 - 2008 (Research Fellow)
Current Position: Executive Director, Next Generation Diagnostics at Novartis Institutes for BioMedical Research
Jordi Barretina, PhD
Member 2005 - 2008 (Research Fellow)
PhD, Universitat Autonoma de Barcelona, Spain
Current Position: Lab Head, Oncology Translational Research at Novartis
I am currently the Lead Scientist of The Cancer Cell Line Encyclopedia (CCLE) project, a collaboration between the Broad Institute, the Novartis Institutes for Biomedical Research and the Genomics Institute of the Novartis Research Foundation. The goals of this project are to conduct a detailed genetic and pharmacologic characterization of a large panel of human cancer models, to develop integrated computational analyses that link distinct pharmacologic vulnerabilities to genomic patterns and to translate cell line integrative genomics into cancer patient stratification.
Email Dr. Barretina
Member 2005 - 2008 (Research Fellow)
PhD, Universitat Autonoma de Barcelona, Spain
Current Position: Lab Head, Oncology Translational Research at Novartis
I am currently the Lead Scientist of The Cancer Cell Line Encyclopedia (CCLE) project, a collaboration between the Broad Institute, the Novartis Institutes for Biomedical Research and the Genomics Institute of the Novartis Research Foundation. The goals of this project are to conduct a detailed genetic and pharmacologic characterization of a large panel of human cancer models, to develop integrated computational analyses that link distinct pharmacologic vulnerabilities to genomic patterns and to translate cell line integrative genomics into cancer patient stratification.
Email Dr. Barretina
Barbara Weir, PhD
Member 2003 - 2008 (Research Fellow)
Current Position: Research Scientist II, Cancer Program, Broad Institute
I'm working with Dr. Bill Hahn to functionally profile large numbers of cancer cell lines using large-scale, pooled shRNA screens. I hope to integrate this data with findings from genome-wide studies of molecular alterations (mutations, copy number changes, etc.) in cancer.
(617) 714-7556
Email Dr. Weir
Member 2003 - 2008 (Research Fellow)
Current Position: Research Scientist II, Cancer Program, Broad Institute
I'm working with Dr. Bill Hahn to functionally profile large numbers of cancer cell lines using large-scale, pooled shRNA screens. I hope to integrate this data with findings from genome-wide studies of molecular alterations (mutations, copy number changes, etc.) in cancer.
(617) 714-7556
Email Dr. Weir
Orit Rozenblatt-Rosen, PhD
Member 2001 - 2008 (Research Fellow)
PhD, Weizmann Institute of Science, Israel
Current Position: Associate Director, Klarman Cell Observatory, Broad Institute
617-714-7789
Email Dr. Rozenblatt-Rosen
Member 2001 - 2008 (Research Fellow)
PhD, Weizmann Institute of Science, Israel
Current Position: Associate Director, Klarman Cell Observatory, Broad Institute
617-714-7789
Email Dr. Rozenblatt-Rosen
Gordon Saksena, PhD
Member since 2009
Current Position: Senior Software Engineer, Broad Institute
I take computational algorithms that have cleared the proof-of-concept phase, and make them fast and robust. I also create software infrastructure that streamlines this process for future algorithms.
(617) 714-7606
Email Dr. Saksena
Member since 2009
Current Position: Senior Software Engineer, Broad Institute
I take computational algorithms that have cleared the proof-of-concept phase, and make them fast and robust. I also create software infrastructure that streamlines this process for future algorithms.
(617) 714-7606
Email Dr. Saksena
Naveen Sangji, MD, MPH
Member 2006 - 2007
Current Position: General Surgery, Massachusetts General Hospital
Email Dr. Sangji
Member 2006 - 2007
Current Position: General Surgery, Massachusetts General Hospital
Email Dr. Sangji
Roman Thomas, MD, PhD
Member 2004 - 2006 (Research Fellow)
Current Position: Professor and Chair, Department of Translational Genomics, University of Cologne
My focus is on lung cancer genomics and the implications for cancer therapy. We conduct genomics analyses of primary lung cancer specimens and perform cell biology analyses aimed at characterizing the functional implications of genomic alterations found in the primary tumors. A central aspect of these functional efforts is to identify potential therapeutic opportunities.
Email Dr. Thomas
Member 2004 - 2006 (Research Fellow)
Current Position: Professor and Chair, Department of Translational Genomics, University of Cologne
My focus is on lung cancer genomics and the implications for cancer therapy. We conduct genomics analyses of primary lung cancer specimens and perform cell biology analyses aimed at characterizing the functional implications of genomic alterations found in the primary tumors. A central aspect of these functional efforts is to identify potential therapeutic opportunities.
Email Dr. Thomas
Thomas LaFramboise, PhD
Member 2004 - 2006 (Research Fellow)
Current Position: Associate Professor, Department of Genetics and Genome Sciences, Case Western Reserve University
My laboratory's focus is on high-dimensional data mining to understand cancer initiation, progression, and metastasis. Long term, we are specifically interested in developing early-detection protocols.
216-368-0150
The LaFramboise Laboratory
Email Dr. LaFramboise
Member 2004 - 2006 (Research Fellow)
Current Position: Associate Professor, Department of Genetics and Genome Sciences, Case Western Reserve University
My laboratory's focus is on high-dimensional data mining to understand cancer initiation, progression, and metastasis. Long term, we are specifically interested in developing early-detection protocols.
216-368-0150
The LaFramboise Laboratory
Email Dr. LaFramboise
Torstein Tengs, PhD
Member 2002 - 2005 (Research Fellow)
Current Position: Senior Scientist, National Veterinary Institute (Norway)
I work on emerging diseases and unknown pathogens in fish and other animals.
(+47) 23 21 64 70
Email Dr. Tengs
Member 2002 - 2005 (Research Fellow)
Current Position: Senior Scientist, National Veterinary Institute (Norway)
I work on emerging diseases and unknown pathogens in fish and other animals.
(+47) 23 21 64 70
Email Dr. Tengs